Drug Profile
Research programme: GPCR modulators - Nxera Pharma/New York University School of Medicine
Alternative Names: G protein-coupled receptor modulators - Nxera Pharma/New York University School of MedicineLatest Information Update: 02 Apr 2024
Price :
$50
*
At a glance
- Originator Heptares Therapeutics; New York University School of Medicine
- Developer New York University School of Medicine; Nxera Pharma
- Class Antineoplastics
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Glioblastoma